Skip to Content

Thrivent International Allocation A TWAAX

Medalist Rating as of | See Thrivent Investment Hub
  • NAV / 1-Day Return 10.12  /  −0.30 %
  • Total Assets 733.0 Mil
  • Adj. Expense Ratio
    1.170%
  • Expense Ratio 1.170%
  • Distribution Fee Level Average
  • Share Class Type Front Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 2,000
  • Status Open
  • TTM Yield 2.60%
  • Turnover 92%

USD | NAV as of Apr 19, 2024 | 1-Day Return as of Apr 19, 2024, 10:18 PM GMT+0

Morningstar’s Analysis TWAAX

Will TWAAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin Thrivent International Allocation A's Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings TWAAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 18.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

MSCI EAFE Index Future Mar 24

6.15 47.7 Mil

Thrivent Core Short-Term Reserve Fund

3.90 30.2 Mil
Cash and Equivalents

Novartis AG Registered Shares

2.30 17.8 Mil
Healthcare

ASML Holding NV

2.09 16.2 Mil
Technology

Shell PLC

1.34 10.4 Mil
Energy

Sanofi SA

1.28 9.9 Mil
Healthcare

Novo Nordisk A/S Class B

1.22 9.5 Mil
Healthcare

CSL Ltd

1.22 9.4 Mil
Healthcare

Toyota Motor Corp

1.19 9.2 Mil
Consumer Cyclical

AstraZeneca PLC

1.07 8.3 Mil
Healthcare